healthcare

First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
August 3, 2021

  • Breakthrough results in the treatment of a type of heart failure, which...

    Continue Reading >
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
August 3, 2021

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals......

Continue Reading >
SBA holds Covid-19 vaccination drive
August 2, 2021

MUSCAT: To safeguard the health and safety of its employees and customers against the spread of Covid-19, Suhail Bahwan Automobiles (SBA) has initiated......

Continue Reading >
AstraZeneca says COVID-19 vaccine sales top $1bn -
August 1, 2021

British pharmaceuticals giant AstraZeneca said that its COVID-19 jab generated US$1.2bn in sales in the first half of the year as global vaccination......

Continue Reading >
Singer-Songwriter Charlie Marie Lyons and Dikembe Mutombo Foundation Ally to Support School Construction in Congo
August 1, 2021

Los Angeles, July 26, 2021 – The philanthropic work of NBA Global Ambassador Dikembe Mutombo is the inspiration for Los Angeles-based singer-songwriter......

Continue Reading >
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
July 31, 2021

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch......

Continue Reading >
IWBI Collaborates with Leading Organizations to Launch WELL Enterprise Provider Designation
July 30, 2021

The International WELL Building Institute (IWBI) today launched the WELL Enterprise Provider (WELL EP) designation for organizations that demonstrate......

Continue Reading >
Sultanate sees 55% fall in hepatitis patients
July 29, 2021

Patients with viral hepatitis decreased by 55 per cent to 133 in 2020 compared to 260 in 2019, according to the National Centre for Statistics and......

Continue Reading >
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)
July 28, 2021

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA)......

Continue Reading >